These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 22776955)

  • 1. In vitro evaluation of major in vivo drug metabolic pathways using primary human hepatocytes and HepaRG cells in suspension and a dynamic three-dimensional bioreactor system.
    Darnell M; Ulvestad M; Ellis E; Weidolf L; Andersson TB
    J Pharmacol Exp Ther; 2012 Oct; 343(1):134-44. PubMed ID: 22776955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
    Zanelli U; Caradonna NP; Hallifax D; Turlizzi E; Houston JB
    Drug Metab Dispos; 2012 Jan; 40(1):104-10. PubMed ID: 21998403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of organic anion-transporting polypeptide 1B1 and CYP3A4 activities in primary human hepatocytes and HepaRG cells cultured in a dynamic three-dimensional bioreactor system.
    Ulvestad M; Darnell M; Molden E; Ellis E; Åsberg A; Andersson TB
    J Pharmacol Exp Ther; 2012 Oct; 343(1):145-56. PubMed ID: 22789711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
    Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
    J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The suitability of hepatocyte culture models to study various aspects of drug metabolism.
    Nussler AK; Wang A; Neuhaus P; Fischer J; Yuan J; Liu L; Zeilinger K; Gerlach J; Arnold PJ; Albrecht W
    ALTEX; 2001; 18(2):91-101. PubMed ID: 11378681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extending hepatocyte functionality for drug-testing applications using high-viscosity alginate-encapsulated three-dimensional cultures in bioreactors.
    Miranda JP; Rodrigues A; Tostões RM; Leite S; Zimmerman H; Carrondo MJ; Alves PM
    Tissue Eng Part C Methods; 2010 Dec; 16(6):1223-32. PubMed ID: 20184401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450-dependent metabolism in HepaRG cells cultured in a dynamic three-dimensional bioreactor.
    Darnell M; Schreiter T; Zeilinger K; Urbaniak T; Söderdahl T; Rossberg I; Dillnér B; Berg AL; Gerlach JC; Andersson TB
    Drug Metab Dispos; 2011 Jul; 39(7):1131-8. PubMed ID: 21436404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of three human in vitro systems in the generation of major human excretory and circulating metabolites.
    Dalvie D; Obach RS; Kang P; Prakash C; Loi CM; Hurst S; Nedderman A; Goulet L; Smith E; Bu HZ; Smith DA
    Chem Res Toxicol; 2009 Feb; 22(2):357-68. PubMed ID: 19146377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-depth physiological characterization of primary human hepatocytes in a 3D hollow-fiber bioreactor.
    Mueller D; Tascher G; Müller-Vieira U; Knobeloch D; Nuessler AK; Zeilinger K; Heinzle E; Noor F
    J Tissue Eng Regen Med; 2011 Aug; 5(8):e207-18. PubMed ID: 21442764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional HepaRG model as an attractive tool for toxicity testing.
    Leite SB; Wilk-Zasadna I; Zaldivar JM; Airola E; Reis-Fernandes MA; Mennecozzi M; Guguen-Guillouzo C; Chesne C; Guillou C; Alves PM; Coecke S
    Toxicol Sci; 2012 Nov; 130(1):106-16. PubMed ID: 22843569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.
    Anthérieu S; Chesné C; Li R; Camus S; Lahoz A; Picazo L; Turpeinen M; Tolonen A; Uusitalo J; Guguen-Guillouzo C; Guillouzo A
    Drug Metab Dispos; 2010 Mar; 38(3):516-25. PubMed ID: 20019244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells.
    Aninat C; Piton A; Glaise D; Le Charpentier T; Langouët S; Morel F; Guguen-Guillouzo C; Guillouzo A
    Drug Metab Dispos; 2006 Jan; 34(1):75-83. PubMed ID: 16204462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures.
    Yokoyama Y; Sasaki Y; Terasaki N; Kawataki T; Takekawa K; Iwase Y; Shimizu T; Sanoh S; Ohta S
    Biol Pharm Bull; 2018 May; 41(5):722-732. PubMed ID: 29445054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies.
    Kanebratt KP; Andersson TB
    Drug Metab Dispos; 2008 Jul; 36(7):1444-52. PubMed ID: 18385292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New perspectives in the use of human hepatocytes in the preclinical drug development process].
    Guillouzo A
    Ann Pharm Fr; 2008; 66(5-6):288-95. PubMed ID: 19061728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance.
    McGinnity DF; Soars MG; Urbanowicz RA; Riley RJ
    Drug Metab Dispos; 2004 Nov; 32(11):1247-53. PubMed ID: 15286053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of a micropatterned hepatocyte coculture system to generate major human excretory and circulating drug metabolites.
    Wang WW; Khetani SR; Krzyzewski S; Duignan DB; Obach RS
    Drug Metab Dispos; 2010 Oct; 38(10):1900-5. PubMed ID: 20595376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human.
    Andersson TB; Kanebratt KP; Kenna JG
    Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):909-20. PubMed ID: 22568886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human hepatocytes: isolation, cryopreservation and applications in drug development.
    Li AP
    Chem Biol Interact; 2007 May; 168(1):16-29. PubMed ID: 17270162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.